Contraception in adolescents with obesity and diabetes mellitus

Author:

Shaydullina M. R.1ORCID,Valeeva F. V.2ORCID,Soubchankoulova A. F.2ORCID,Khusieva P. A.3ORCID

Affiliation:

1. Kazan State Medical University; Republican Сhildren’s Clinical Hospital

2. Kazan State Medical University

3. Republican Сhildren’s Clinical Hospital

Abstract

Today most adolescents have their first sexual experience at the age of 15–19. However, only 44% of girls and young women (15–24 years old) report about contraception at that moment. A decision on pregnancy in adolescence is a difficult choice and any scenario may cause serious medical and social problems. Complications after an artificial abortion have a negative impact on a woman’s fertility. Diabetes mellitus type 1 and arterial hypertension accompanied with obesity within the metabolic syndrome are defined by the World Health Organization (WHO) as diseases, which increase risk of an unplanned pregnancy. The article consoders problems of interaction of a doctor and a teenage girl with endocrinopathy, when discussing her sexual health, the analysis of the literature reflecting the influence of contraception on the course of the underlying pathology is presented. The authors formed a list of drugs acceptable for use in diabetes and obesity based on assessment of risks and preferences from the use of different methods of fertility control. The work contains information about the procedure of starting contraception, the rules of future dynamic monitoring of the patient.

Publisher

Endocrinology Research Centre

Subject

Endocrinology, Diabetes and Metabolism

Reference59 articles.

1. Chandra-Mouli V, Akwara E. Improving access to and use of contraception by adolescents: What progress has been made, what lessons have been learnt, and what are the implications for action? Best Pract Res Clin Obstet Gynaecol. 2020;66:107-118. doi: https://doi.org/10.1016/j.bpobgyn.2020.04.003

2. Osnovnye pokazateli zdorov’ja materi i rebenka, dejatel’nost’ sluzhby ohrany detstva i rodovspomozhenija v Rossijskoj Federacii. Moscow: FGBU «CNIIOIZ» Minzdrava Rossijskoj Federacii; 2019, 169 p. ( In Russ.).

3. Medical eligibility criteria for contraceptive use – 5th ed [Internet]. Geneva: World Health Organization; 2015. Available from: https://www.who.int/publications/i/item/9789241549158

4. Rezjume otcheta «Reproduktivnoe zdorov’e naselenija Rossii 2011». Federal’naja sluzhba gosudarstvennoj statistiki (Rosstat). Moscow; Ministerstvo zdravoohranenija Rossijskoj Federacii; 2012. 60 p. ( In Russ.).

5. Ugolovnyi kodeks Rossiĭskoĭ Federatsii v red. Federal Law No 380 ot 28 dekabrya 2013. (In Russ.).

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3